The rising interest in GLP-1 agonists for weight control has led to a question about application forms : transdermal systems versus pills . Typically, GLP-1 treatments were only available in tablet form, but the introduction of transdermal delivery offers a different choice . Patches might be advantageous for individuals facing difficulty with tabl